Sandostatin LAR depot 30 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26F9PD9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,577
Award facts
- Contract value 100% obligated
- $43,577.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,577.04 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. This firm fixed-price, non-set-aside contract was awarded on February 3, 2026, with an ultimate completion date of February 4, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling government requirements for brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Sandostatin LAR Depot—an acromegaly and neuroendocrine tumor treatment—exemplifies the company's role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare programs through the DLA's comprehensive pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9PD9?
SPE2DR26F9PD9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F9PD9 worth?
The government has obligated $43,577 on SPE2DR26F9PD9.
Is contract SPE2DR26F9PD9 an order under another contract?
Yes. SPE2DR26F9PD9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PD9 competed?
The extent of competition for SPE2DR26F9PD9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award